Population-Based Study of Epilepsy in Cambodia Associated Factors, Measures of Impact, Stigma, Quality of Life, Knowledge-Attitude-Practice, and Treatment Gap

Identify epilepsy-associated factors and calculate measures of impact, stigma, quality of life (QOL), knowledge-attitude-practice (KAP) and treatment gap in Prey Veng, Cambodia. This first Cambodian population-based case-control study had 96 epileptologist-confirmed epilepsy cases and 192 randomly s...

Full description

Saved in:
Bibliographic Details
Published inPloS one Vol. 7; no. 10; p. e46296
Main Authors Bhalla, Devender, Chea, Kimly, Hun, Chamroeun, Vannareth, Mey, Huc, Pierre, Chan, Samleng, Sebbag, Robert, Gérard, Daniel, Dumas, Michel, Oum, Sophal, Druet-Cabanac, Michel, Preux, Pierre-Marie
Format Journal Article
LanguageEnglish
Published United States Public Library of Science 15.10.2012
Public Library of Science (PLoS)
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Identify epilepsy-associated factors and calculate measures of impact, stigma, quality of life (QOL), knowledge-attitude-practice (KAP) and treatment gap in Prey Veng, Cambodia. This first Cambodian population-based case-control study had 96 epileptologist-confirmed epilepsy cases and 192 randomly selected matched healthy controls. Standard questionnaires, which have been used in similar settings, were used for collecting data on various parameters. Univariate and multivariate regression was done to determine odds ratios. Jacoby stigma, 31-item QOL, KAP etc were determined and so were the factors associated with them using STATA software. Treatment gap was measured using direct method. Multivariate analyses yielded family history of epilepsy, difficult or long delivery, other problems beside seizures (mainly mental retardation, hyperthermia), and eventful pregnancy of the subject's mother as factors associated with epilepsy. There was high frequency of seizure precipitants esp. those related to sleep. Population attributable risk (%) was: family history (15.0), eventful pregnancy of subject's mother (14.5), long/difficult birth (6.5), and other problem beside seizures (20.0). Mean stigma (1.9±1.1, on a scale of 3) was mainly related to treatment efficacy. Mean QOL (5.0±1.4 on a scale of 10) was mainly related to treatment regularity. Cause or risk factor could be determined in 56% of cases. Treatment gap was 65.8%. Factors in pre- and perinatal period were found to be most crucial for epilepsy risk in Cambodia which inturn provides major prevention opportunities. A global action plan for treatment, stigma reduction and improvement of QOL should be set-up in this country.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
PMCID: PMC3471879
Conceived and designed the experiments: DB P-MP MD MD-C SO SC. Performed the experiments: DB KC PH MV CH MD P-MP. Analyzed the data: DB. Contributed reagents/materials/analysis tools: DB P-MP MD-C KC. Wrote the paper: DB. Overall supervision: P-MP MD-C MD SO SC DG RS.
Competing Interests: Corresponding author, Prof. Pierre-Marie Preux is the Plos One editorial board member. Drs Robert Sebbag and Daniel Gérard are employees of Sanofi France and the authors have received financial support from the department of access to medicines, Sanofi, Gentilly, France, there are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0046296